Search Results
ctDNA testing for MRD – Reliable, sensitive, and specific, but challenges remain: 2022 ESMO Florida
Is MRD testing a Standard of Care?
A flurry of new drug development and approvals in breast cancer: 2022 ESMO Florida
Emerging Role of Circulating Tumor DNA in the Management of Thoracic Malignancies (Sept. 26, 2024)
Int'l MTC Grading System: A Validated Grading System for MTC with Dr. Ghossein
Gastrointestinal Cancers | Proceedings from a symposium in partnership with NCOA and SCOS
Emerging Role of Circulating Tumor DNA in GIST
Recent Advances and Future Directions in Gastrointestinal Cancers — With Dr Tanios Bekaii-Saab an...
Unraveling the Genomics in Lung Cancer & Liquid biopsy in NSCLC
Yale Cancer Center Grand Rounds | October 6, 2023
ER+ Breast Cancer Case Panel Discussion | 2022 Best of Breast Conference
From concept to indication: Neoadjuvant immunotherapy for operable lung cancer
